Data for Omicron-Specific Shot Likely Available in March: Moderna
Moderna's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks, CEO Stephane Bancel said on Monday.
Reuters Health Information
source https://www.medscape.com/viewarticle/966705?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/966705?src=rss
Comments
Post a Comment